News

Pharmaceutical Commerce's latest report finds continued growth in these specialized logistics services

Voluntary recall of all products in the US and Puerto Rico has begun

Pharma companies assess their ongoing reporting capabilities

Annual survey tracks rapid evolution in a critical pharma market

Expanded cold-chain storage, more office space is driven by 40% business growth

Company also announces a 10-year agreement with Salesforce.com

Researchers suggest that the surge in analysis of large data sets may have limitations for understanding healthcare patterns

Award was earned at 2014 BioPharma Asia meeting in Singapore

Clinical Trials Supply Chain Solutions (CTSCS) becomes Clinical Supply Solutions (CSS)

Newly branded company is one of the largest contract development and manufacturing organizations (CDMOs) in the world

Procurement-automation platform could grow beyond its hospital-products roots

Service connects McKesson industry clients to PI's network of e-prescribing and EHRs

Pharma industry is invited into some EHRs, excluded from others

Industry appears to be realigning spending ahead of the Sunshine Act

New reasons why the announced death of this profession will always be premature

What you need to know about the current specialty pharmacy landscape

Things to know about the increasingly popular--and competitive--orphan drug space

Facility will produce both biologics and small molecules

Getting to the 'future state' in cloud computing

Diving for customer insights through an ocean of crowdsourced data

Today's cloud-based, fast-evolving CRM systems call for a closer partnership between vendor and client

AdverseEvents, Inc., finds a receptive client base among managed-care providers

UPS acquires a temperature-controlled ground fleet, while Pelican buys Cool Logistics

Ernst & Young Firepower report sees a 'growth gap' for traditional pharmacos

J&J is the far-and-away leader in the IMS Health Social Media Engagement Index

Efforts of the National Biomarker Development Alliance will address the 'dismal' success rate of approved biomarker diagnostics

Companies are positioning themselves as approved high-volume compounders

Company's integration of Medco is 'largely complete'